International Journal of Chronic Obstructive Pulmonary Disease

Papers
(The H4-Index of International Journal of Chronic Obstructive Pulmonary Disease is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Pulmonary Rehabilitation in a Post-COVID-19 World: Telerehabilitation as a New Standard in Patients with COPD87
Update on Asthma–COPD Overlap (ACO): A Narrative Review47
<p>Updated Perspectives on Pulmonary Hypertension in COPD</p>43
<p>Management of the COPD Patient with Comorbidities: An Experts Recommendation Document</p>38
Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-238
<p>Nebulized Therapies in COPD: Past, Present, and the Future</p>37
<p>FEV<sub>1</sub> is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease</p>35
<p>FEF<sub>25-75%</sub> Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease</p>35
<p>The Experience of COPD Patients in Lockdown Due to the COVID-19 Pandemic</p>34
Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study33
<p>Construction of Potential miRNA–mRNA Regulatory Network in COPD Plasma by Bioinformatics Analysis</p>33
The Relationship Between Anxiety, Depression and Treatment Adherence in Chronic Obstructive Pulmonary Disease: A Systematic Review33
<p>Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial</p>33
Pathological Mechanism and Targeted Drugs of COPD30
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO30
<p>PM2.5 Induces the Expression of Inflammatory Cytokines via the Wnt5a/Ror2 Pathway in Human Bronchial Epithelial Cells</p>29
<p>An Integrative Approach of the Fissure Completeness Score and Chartis Assessment in Endobronchial Valve Treatment for Emphysema</p>29
Xuanbai Chengqi Decoction Ameliorates Pulmonary Inflammation via Reshaping Gut Microbiota and Rectifying Th17/Treg Imbalance in a Murine Model of Chronic Obstructive Pulmonary Disease28
<p>A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future</p>27
A Systematic Literature Review of the Humanistic Burden of COPD27
GOLD 2021 Strategy Report: Implications for Asthma–COPD Overlap27
Stigma Experiences in People with Chronic Obstructive Pulmonary Disease: An Integrative Review26
<p>A Model Using Support Vector Machines Recursive Feature Elimination (SVM-RFE) Algorithm to Classify Whether COPD Patients Have Been Continuously Managed According to GOLD Guidelines</p>26
<p>The Association Between Neighborhood Socioeconomic Disadvantage and Chronic Obstructive Pulmonary Disease</p>26
<p>Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis</p>24
How to Assess Breathlessness in Chronic Obstructive Pulmonary Disease24
Towards Personalized Management of Sarcopenia in COPD24
<p>Predictors of Referral to Pulmonary Rehabilitation from UK Primary Care</p>24
0.065232992172241